Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Clinical Immunology (Orlando, Fla.)|March 17, 1999
Selection of hprt mutant T cells as surrogates for dividing cells reveals a restricted T cell receptor BV repertoire in insulin-dependent diabetes mellitusM T Falta, G K Magin, M Allegretta, et al.Cancer Research|April 1, 1985
Cell-mediated inhibition of tumor colony formation in agarose by resting and interleukin 2-stimulated human lymphocytesE C Bradley, J J Catino, B F Issell, et al.The Journal of Clinical Investigation|July 1, 1994
Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitisM Allegretta, R J Albertini, M D Howell, et al.Journal of Clinical Immunology|November 1, 1986
The development of anti-interleukin-2 antibodies in patients treated with recombinant human interleukin-2 (IL-2)M Allegretta, M B Atkins, R A Dempsey, et al.Mutation Research|October 1, 1994
The effect of T-lymphocyte 'clonality' on the calculated hprt mutation frequency occurring in vivo in humansJ P O'Neill, J A Nicklas, T C Hunter, et al.Environmental and Molecular Mutagenesis|January 1, 1988
Molecular analyses of in vivo hypoxanthine-guanine phosphoribosyltransferase mutations in human T-lymphocytes: II. Demonstration of a clonal amplification of hprt mutant T-lymphocytes in vivoJ A Nicklas, J P O'Neill, L M Sullivan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant diseaseM B Atkins, J A Gould, M Allegretta, et al.American Journal of Hematology|August 1, 1987
Malignant granular lymphoproliferation after Epstein-Barr virus infection: partial immunologic reconstitution with interleukin-2F R Aronson, R A Dempsey, M Allegretta, et al.Journal of Neuroimmunology|May 5, 1999
IL-7 enhances Ag-specific human T cell response by increasing expression of IL-2R alpha and gamma chainsY K Chou, D N Bourdette, D Barnes, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1998
Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genesD N Bourdette, Y K Chou, R H Whitham, et al.Pageof 3